Edges in Network
| Network | GSE25055_egf1520 - GSE25055 - SiGN-BN HC+Bootstrap |
| Network Description | Discovery cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
| Node | MAP3K5 |
| Upstream (Parents) |
|---|
| (<<) ADAM10 → MAP3K5 |
| (<<) ALDOA → MAP3K5 |
| (<<) AQP3 → MAP3K5 |
| (<<) CASP1 → MAP3K5 |
| (<<) CASP4 → MAP3K5 |
| (<<) CDK4 → MAP3K5 |
| (<<) CLEC2B → MAP3K5 |
| (<<) CTSF → MAP3K5 |
| (<<) DAB2 → MAP3K5 |
| (<<) DUSP5 → MAP3K5 |
| (<<) EFNB1 → MAP3K5 |
| (<<) EGFR → MAP3K5 |
| (<<) ETS2 → MAP3K5 |
| (<<) FAS → MAP3K5 |
| (<<) FZD6 → MAP3K5 |
| (<<) GAPDH → MAP3K5 |
| (<<) GBP2 → MAP3K5 |
| (<<) GYS1 → MAP3K5 |
| (<<) HOPX → MAP3K5 |
| (<<) JAK1 → MAP3K5 |
| (<<) MSN → MAP3K5 |
| (<<) NFKB1 → MAP3K5 |
| (<<) NR3C1 → MAP3K5 |
| (<<) PTGER4 → MAP3K5 |
| (<<) PTPRE → MAP3K5 |
| (<<) ROR1 → MAP3K5 |
| (<<) SGK1 → MAP3K5 |
| (<<) SH3GLB1 → MAP3K5 |
| (<<) STK17B → MAP3K5 |
| (<<) SULT1A2 → MAP3K5 |
| (<<) TCEB1 → MAP3K5 |
| Downstream (Children) |
|---|
| MAP3K5 → ARHGAP10 (>>) |
| MAP3K5 → CEBPD (>>) |
| MAP3K5 → CENPF (>>) |
| MAP3K5 → ETS1 (>>) |
| MAP3K5 → F2RL1 (>>) |
| MAP3K5 → FGFR2 (>>) |
| MAP3K5 → FHIT (>>) |
| MAP3K5 → FZD10 (>>) |
| MAP3K5 → GLRX (>>) |
| MAP3K5 → GNA15 (>>) |
| MAP3K5 → HDAC4 (>>) |
| MAP3K5 → KCNJ5 (>>) |
| MAP3K5 → MYL6B (>>) |
| MAP3K5 → PRKCI (>>) |
| MAP3K5 → RARB (>>) |
| MAP3K5 → RDH16 (>>) |
| MAP3K5 → RORA (>>) |
| MAP3K5 → SOX17 (>>) |
| MAP3K5 → STK17A (>>) |
| MAP3K5 → TGFB2 (>>) |
| MAP3K5 → UST (>>) |
| MAP3K5 → WNT3 (>>) |
